qeasl 3d semiautomated tumor segmentation software intellispace portal v8 (Medisys Innovation Pte Ltd)
90
Structured Review
Medisys Innovation Pte Ltd
qeasl 3d semiautomated tumor segmentation software intellispace portal v8
Qeasl 3d Semiautomated Tumor Segmentation Software Intellispace Portal V8, supplied by Medisys Innovation Pte Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+segmentation+software/3d+tumor+segmentation+software/pm39033181-61-3-20
Average 90 stars, based on 1 article reviews
Qeasl 3d Semiautomated Tumor Segmentation Software Intellispace Portal V8, supplied by Medisys Innovation Pte Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+segmentation+software/3d+tumor+segmentation+software/pm39033181-61-3-20
Average 90 stars, based on 1 article reviews
qeasl 3d semiautomated tumor segmentation software intellispace portal v8 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure Article Snippet: .. Article Title: Accuracy of a Cone-Beam CT Virtual Parenchymal Perfusion Algorithm for Liver Cancer Targeting during Intra-arterial Therapy. Article Snippet: Purpose: To evaluate accuracy of virtual parenchymal perfusion (VPP) algorithm developed for targeting liver cancer during intraarterial therapy (IAT) using cone-beam CT guidance.. Materials and Methods: VPP was retrospectively applied to 15 patients who underwent IAT for liver cancer.. Virtual territory (VT) was estimated after positioning a virtual injection point on nonselective dual-phase (DP) cone-beam CT images acquired during hepatic arteriography at the same position chosen for selective treatment. Article Title: The Impact of Antiangiogenic Therapy Combined With Transarterial Chemoembolization on Enhancement Based Quantitative Tumor Response Assessment in Patients With Hepatocellular Carcinoma Article Snippet: .. With a Article Title: Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria. Article Snippet: .. 3D tumor response assessment The three observers independently performed 3D quantitative tumor assessment using a Article Title: Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making. Article Snippet: Objective To compare the performance of 1D and 3D tumor response assessment for predicting median overall survival (mOS) in patients who underwent immunotherapy for hepatocellular carcinoma (HCC).. Methods Patients with HCC who underwent immunotherapy between 2017 and 2023 and received multi-phasic contrast-enhanced MRIs preand post-treatment were included in this retrospective study.. Tumor response was measured using 1D, RECIST 1.1, and mRECIST, and 3D, volumetric, and percentage quantitative EASL (vqEASL and % qEASL). Article Title: Lipiodol Deposition and Washout in Primary and Metastatic Liver Tumors After Chemoembolization Article Snippet: .. A Article Title: The Impact of Antiangiogenic Therapy Combined With Transarterial Chemoembolization on Enhancement Based Quantitative Tumor Response Assessment in Patients With Hepatocellular Carcinoma Article Snippet: .. Image processing and analysis With a Imaging:Article Title: Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making. Article Snippet: Objective To compare the performance of 1D and 3D tumor response assessment for predicting median overall survival (mOS) in patients who underwent immunotherapy for hepatocellular carcinoma (HCC).. Methods Patients with HCC who underwent immunotherapy between 2017 and 2023 and received multi-phasic contrast-enhanced MRIs preand post-treatment were included in this retrospective study.. Tumor response was measured using 1D, RECIST 1.1, and mRECIST, and 3D, volumetric, and percentage quantitative EASL (vqEASL and % qEASL). |
